Pfizer Inc. is an active Californian business entity incorporated 25th June 1951. C T Corporation System acts as the agent for this company.
Company Data
| Company Name | Pfizer Inc. |
|---|---|
| Company Agent | C T Corporation System |
| Company Status | Active |
| Entity Number | 255105 |
| Entity Type | Stock Corporation - Out of State - Stock |
| Jurisdiction | Delaware |
| Incorporation Date | 25 June 1951 (72 years, 10 months ago) |
| Statement of Info | Due 30 June 2024 |
Principal & Mailing Address
| Address | 66 Hudson Boulevard East New York, NY 10001-2192 |
|---|---|
| Map |
Agent
| Agent Details | 1505 Corporation C T Corporation System |
|---|
History
| 30 June 2023 | Statement of Information BA20231042364
| |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2 June 2023 | Publicly Traded Corporate Disclosure Statement BA20230924945 | |||||||||
| 12 April 2023 | Statement of Information BA20230609348
| |||||||||
| 1 June 2022 | Publicly Traded Corporate Disclosure Statement BA20220470596 | |||||||||
| 2 June 2021 | Publicly Traded Corporate Disclosure Statement LBA10839793
| |||||||||
| 29 May 2020 | Publicly Traded Corporate Disclosure Statement LBA10839792
| |||||||||
| 4 June 2019 | Publicly Traded Corporate Disclosure Statement LBA10839791
| |||||||||
| 1 June 2018 | Publicly Traded Corporate Disclosure Statement LBA10839790
| |||||||||
| 1 June 2017 | Publicly Traded Corporate Disclosure Statement LBA10839789
| |||||||||
| 1 June 2016 | Publicly Traded Corporate Disclosure Statement LBA10839788
| |||||||||
| 4 June 2015 | Publicly Traded Corporate Disclosure Statement LBA10839787
| |||||||||
| 30 May 2014 | Publicly Traded Corporate Disclosure Statement LBA10839786
| |||||||||
| 4 June 2013 | Publicly Traded Corporate Disclosure Statement LBA10839785
| |||||||||
| 4 June 2012 | Publicly Traded Corporate Disclosure Statement LBA10839784
| |||||||||
| 31 May 2011 | Publicly Traded Corporate Disclosure Statement LBA10839783
| |||||||||
| 13 September 2010 | Publicly Traded Corporate Disclosure Statement LBA10839782
| |||||||||
| 3 June 2009 | Publicly Traded Corporate Disclosure Statement LBA10839781
| |||||||||
| 2 June 2008 | Publicly Traded Corporate Disclosure Statement LBA10839780
| |||||||||
| 22 June 2007 | Publicly Traded Corporate Disclosure Statement LBA10839779
| |||||||||
| 1 June 2007 | Publicly Traded Corporate Disclosure Statement LBA10839778
| |||||||||
| 15 June 2006 | Publicly Traded Corporate Disclosure Statement LBA10839777
| |||||||||
| 1 June 2005 | Publicly Traded Corporate Disclosure Statement LBA10839776
| |||||||||
| 20 July 2004 | Publicly Traded Corporate Disclosure Statement LBA10839775
| |||||||||
| 5 November 2003 | System Amendment - SI Delinquency for the year of 0 LBA10839774 | |||||||||
| 10 October 2003 | Publicly Traded Corporate Disclosure Statement LBA10839773
| |||||||||
| 9 February 1994 | System Amendment - FTB Restore LBA10839772 | |||||||||
| 1 February 1994 | System Amendment - FTB Forfeited LBA10839771 | |||||||||
| 25 June 1951 | Initial Filing 0255105 |
This page was last updated October 2023.